Skip to content

Evaluate the effectiveness of low dose intravenous ketamine for prevention of shivering in patients undergoing elective cesarean section under spinal anaesthesia.

A randomized, controlled study to evaluate the effectiveness of intravenous low-dose Ketamine versus placebo for prevention of shivering in patients undergoing elective cesarean section under spinal anaesthesia at SMS Medical College and Hospital, Jaipur. - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2026/05/111367
Enrollment
150
Registered
2026-05-29
Start date
Unknown
Completion date
Unknown
Last updated
2026-06-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: O00-O9A- Pregnancy, childbirth and the puerperium

Interventions

Intervention1: Intravenous low dose Ketamine is required for shivering after spinal anaesthesia.: The drug ketamine in dose of 0.25 mg/kg will be given to the patients who starts having shivering afte

Sponsors

Sawai Man Singh Medical College and attached hospitals, Jaipur
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Patient consenting to participate belonging to American Society of Anaesthesiologist (ASA) II undergoing elective lower segment cesarean section under spinal anaesthesia.

Exclusion criteria

Exclusion criteria: Patient not consenting to participate Patient with obstetric emergencies (eg: antepartum hemorrhage, cord prolapse, fetal distress, etc) Patient with systemic illnesses (eg: hypertension, cardiovascular disease, diabetes mellitus, etc) Patient with coagulopathies Patient who needed blood transfusion during surgery or who received medications likely to alter thermoregulation Patient with initial temperature more than 38 C or less than 36 C Patient with history of alcohol or substance abuse Patient with morbid obesity Patient with history of drug hypersensitivity

Design outcomes

Primary

MeasureTime frame
To assess and compare the incidence of shivering between both study groups.Timepoint: To assess and compare the incidence of shivering between both study groups at 5-10-15-20-25-30-35-40-45-50-55-60 minutes

Secondary

MeasureTime frame
1 To assess & compare the duration & severity of shivering between both the study groups 2 To assess & compare changes in hemodynamic parameters (heart rate, systolic, diastolic, & mean blood pressure, core body temperature) between both the study groups. 3 To assess & compare incidence of side effects like nausea, vomiting, hallucinations, nystagmus, excessive salivation, etc. between both the study groupsTimepoint: 1 To assess & compare the duration & severity of shivering between both the study groups every 5 minutes 2 To assess & compare changes in hemodynamic parameters (heart rate, systolic, diastolic, & mean blood pressure, core body temperature) between both the study groups every 5 minutes 3 To assess & compare incidence of side effects like nausea, vomiting, hallucinations, nystagmus, excessive salivation, etc. between both the study groups every 5 minutes

Countries

India

Contacts

Public ContactDr Shubham Garg

SMS Medical College

vkothari66@gmail.com9828020186

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Jun 11, 2026